0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contraceptive Drugs and Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: December 2022
|
Report Code: QYRE-Auto-33Q9214
Home | Market Reports | Health| Reproductive Health
Global Contraceptive Drugs and Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global Contraceptive Drugs and Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-33Q9214
Report
December 2022
Pages:117
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Contraceptive Drugs and Devices estimated at US$ 6844 million in the year 2022, is projected to reach a revised size of US$ 8873.2 million by 2028, growing at a CAGR of 4.4% during the forecast period 2022-2028.

The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Contraceptive Drugs and Devices manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Contraceptive Drugs and Devices market. Further, it explains the major drivers and regional dynamics of the global Contraceptive Drugs and Devices market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Contraceptive Drugs and Devices Segment by Type

Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices

Contraceptive Drugs and Devices Segment by Application

Hospitals
Pharmacies
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Contraceptive Drugs and Devices market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Contraceptive Drugs and Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Contraceptive Drugs and Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Contraceptive Drugs and Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contraceptive Drugs and Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Contraceptive Drugs and Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Contraceptive Drugs and Devices sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer Healthcare, Merck, Church & Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories and Pantarhei Bioscience, etc.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Oral
1.2.3 Vaginal
1.2.4 Injectable Contraceptive Drugs
1.2.5 Male/Female Contraceptive Devices
1.3 Market Segment by Application
1.3.1 Global Contraceptive Drugs and Devices Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Contraceptive Drugs and Devices Market Size (2017-2028)
2.1.1 Global Contraceptive Drugs and Devices Revenue (2017-2028)
2.1.2 Global Contraceptive Drugs and Devices Sales (2017-2028)
2.2 Global Contraceptive Drugs and Devices Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Contraceptive Drugs and Devices Sales by Regions (2017-2022)
2.2.2 Global Contraceptive Drugs and Devices Revenue by Regions (2017-2022)
2.3 Global Contraceptive Drugs and Devices Market Size Forecast by Region
2.3.1 Global Contraceptive Drugs and Devices Sales Forecast by Region (2023-2028)
2.3.2 Global Contraceptive Drugs and Devices Revenue Forecast by Region (2023-2028)
2.4 Global Top Contraceptive Drugs and Devices Regions (Countries) Ranking by Market Size
2.5 Contraceptive Drugs and Devices Market Dynamics
2.5.1 Contraceptive Drugs and Devices Market Trends
2.5.2 Contraceptive Drugs and Devices Market Drivers
2.5.3 Contraceptive Drugs and Devices Market Challenges
2.5.4 Contraceptive Drugs and Devices Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Contraceptive Drugs and Devices Manufacturers by Sales (2017-2022)
3.1.1 Global Contraceptive Drugs and Devices Sales by Manufacturers (2017-2022)
3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Contraceptive Drugs and Devices Sales in 2021
3.2 Global Top Manufacturers Contraceptive Drugs and Devices by Revenue
3.2.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers (2017-2022)
3.2.2 Top Contraceptive Drugs and Devices Manufacturers Covered: Ranking by Revenue
3.2.3 Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Contraceptive Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2021)
3.4 Global Contraceptive Drugs and Devices Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Contraceptive Drugs and Devices Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Contraceptive Drugs and Devices Market
3.7 Key Manufacturers Contraceptive Drugs and Devices Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Contraceptive Drugs and Devices Market Size by Type
4.1 Global Contraceptive Drugs and Devices Historic Market Review by Type (2017-2022)
4.1.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2017-2022)
4.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2022)
4.1.3 Contraceptive Drugs and Devices Price by Type (2017-2022)
4.2 Global Contraceptive Drugs and Devices Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Type (2023-2028)
4.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Type (2023-2028)
4.2.3 Contraceptive Drugs and Devices Price Forecast by Type (2023-2028)
5 Global Contraceptive Drugs and Devices Market Size by Application
5.1 Global Contraceptive Drugs and Devices Historic Market Review by Application (2017-2022)
5.1.1 Global Contraceptive Drugs and Devices Sales Market Share by Application (2017-2022)
5.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2022)
5.1.3 Contraceptive Drugs and Devices Price by Application (2017-2022)
5.2 Global Contraceptive Drugs and Devices Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Application (2023-2028)
5.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Application (2023-2028)
5.2.3 Contraceptive Drugs and Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Contraceptive Drugs and Devices Sales Breakdown by Company
6.1.1 North America Contraceptive Drugs and Devices Sales by Company (2017-2022)
6.1.2 North America Contraceptive Drugs and Devices Revenue by Company (2017-2022)
6.2 North America Contraceptive Drugs and Devices Market Size by Type
6.2.1 North America Contraceptive Drugs and Devices Sales by Type (2017-2028)
6.2.2 North America Contraceptive Drugs and Devices Revenue by Type (2017-2028)
6.3 North America Contraceptive Drugs and Devices Market Size by Application
6.3.1 North America Contraceptive Drugs and Devices Sales by Application (2017-2028)
6.3.2 North America Contraceptive Drugs and Devices Revenue by Application (2017-2028)
6.4 North America Contraceptive Drugs and Devices Market Size by Country
6.4.1 North America Contraceptive Drugs and Devices Sales by Country (2017-2028)
6.4.2 North America Contraceptive Drugs and Devices Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Contraceptive Drugs and Devices Sales Breakdown by Company
7.1.1 Europe Contraceptive Drugs and Devices Sales by Company (2017-2022)
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Company (2017-2022)
7.2 Europe Contraceptive Drugs and Devices Market Size by Type
7.2.1 Europe Contraceptive Drugs and Devices Sales by Type (2017-2028)
7.2.2 Europe Contraceptive Drugs and Devices Revenue by Type (2017-2028)
7.3 Europe Contraceptive Drugs and Devices Market Size by Application
7.3.1 Europe Contraceptive Drugs and Devices Sales by Application (2017-2028)
7.3.2 Europe Contraceptive Drugs and Devices Revenue by Application (2017-2028)
7.4 Europe Contraceptive Drugs and Devices Market Size by Country
7.4.1 Europe Contraceptive Drugs and Devices Sales by Country (2017-2028)
7.4.2 Europe Contraceptive Drugs and Devices Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Contraceptive Drugs and Devices Sales Breakdown by Company
8.1.1 Asia Pacific Contraceptive Drugs and Devices Sales by Company (2017-2022)
8.1.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Company (2017-2022)
8.2 Asia Pacific Contraceptive Drugs and Devices Market Size by Type
8.2.1 Asia Pacific Contraceptive Drugs and Devices Sales by Type (2017-2028)
8.2.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2017-2028)
8.3 Asia Pacific Contraceptive Drugs and Devices Market Size by Application
8.3.1 Asia Pacific Contraceptive Drugs and Devices Sales by Application (2017-2028)
8.3.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2017-2028)
8.4 Asia Pacific Contraceptive Drugs and Devices Market Size by Region
8.4.1 Asia Pacific Contraceptive Drugs and Devices Sales by Region
8.4.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Contraceptive Drugs and Devices Sales Breakdown by Company
9.1.1 Latin America Contraceptive Drugs and Devices Sales by Company (2017-2022)
9.1.2 Latin America Contraceptive Drugs and Devices Revenue by Company (2017-2022)
9.2 Latin America Contraceptive Drugs and Devices Market Size by Type
9.2.1 Latin America Contraceptive Drugs and Devices Sales by Type (2017-2028)
9.2.2 Latin America Contraceptive Drugs and Devices Revenue by Type (2017-2028)
9.3 Latin America Contraceptive Drugs and Devices Market Size by Application
9.3.1 Latin America Contraceptive Drugs and Devices Sales by Application (2017-2028)
9.3.2 Latin America Contraceptive Drugs and Devices Revenue by Application (2017-2028)
9.4 Latin America Contraceptive Drugs and Devices Market Size by Country
9.4.1 Latin America Contraceptive Drugs and Devices Sales by Country (2017-2028)
9.4.2 Latin America Contraceptive Drugs and Devices Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Contraceptive Drugs and Devices Sales Breakdown by Company
10.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Company (2017-2022)
10.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Company (2017-2022)
10.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Type
10.2.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2017-2028)
10.2.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2017-2028)
10.3 Middle East and Africa Contraceptive Drugs and Devices Market Size by Application
10.3.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2017-2028)
10.3.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2017-2028)
10.4 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country
10.4.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2017-2028)
10.4.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Products and Services
11.1.5 Bayer Healthcare Contraceptive Drugs and Devices SWOT Analysis
11.1.6 Bayer Healthcare Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Contraceptive Drugs and Devices Products and Services
11.2.5 Merck Contraceptive Drugs and Devices SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Church & Dwight
11.3.1 Church & Dwight Corporation Information
11.3.2 Church & Dwight Overview
11.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Church & Dwight Contraceptive Drugs and Devices Products and Services
11.3.5 Church & Dwight Contraceptive Drugs and Devices SWOT Analysis
11.3.6 Church & Dwight Recent Developments
11.4 Warmer Chilcott
11.4.1 Warmer Chilcott Corporation Information
11.4.2 Warmer Chilcott Overview
11.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Warmer Chilcott Contraceptive Drugs and Devices Products and Services
11.4.5 Warmer Chilcott Contraceptive Drugs and Devices SWOT Analysis
11.4.6 Warmer Chilcott Recent Developments
11.5 Agile Therapeutics
11.5.1 Agile Therapeutics Corporation Information
11.5.2 Agile Therapeutics Overview
11.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Agile Therapeutics Contraceptive Drugs and Devices Products and Services
11.5.5 Agile Therapeutics Contraceptive Drugs and Devices SWOT Analysis
11.5.6 Agile Therapeutics Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Pfizer Contraceptive Drugs and Devices Products and Services
11.6.5 Pfizer Contraceptive Drugs and Devices SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 BioSante Pharmaceuticals
11.7.1 BioSante Pharmaceuticals Corporation Information
11.7.2 BioSante Pharmaceuticals Overview
11.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Products and Services
11.7.5 BioSante Pharmaceuticals Contraceptive Drugs and Devices SWOT Analysis
11.7.6 BioSante Pharmaceuticals Recent Developments
11.8 Mayer Laboratories
11.8.1 Mayer Laboratories Corporation Information
11.8.2 Mayer Laboratories Overview
11.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Mayer Laboratories Contraceptive Drugs and Devices Products and Services
11.8.5 Mayer Laboratories Contraceptive Drugs and Devices SWOT Analysis
11.8.6 Mayer Laboratories Recent Developments
11.9 Pantarhei Bioscience
11.9.1 Pantarhei Bioscience Corporation Information
11.9.2 Pantarhei Bioscience Overview
11.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Products and Services
11.9.5 Pantarhei Bioscience Contraceptive Drugs and Devices SWOT Analysis
11.9.6 Pantarhei Bioscience Recent Developments
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Overview
11.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Products and Services
11.10.5 Teva Pharmaceutical Industries Contraceptive Drugs and Devices SWOT Analysis
11.10.6 Teva Pharmaceutical Industries Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Contraceptive Drugs and Devices Value Chain Analysis
12.2 Contraceptive Drugs and Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Contraceptive Drugs and Devices Production Mode & Process
12.4 Contraceptive Drugs and Devices Sales and Marketing
12.4.1 Contraceptive Drugs and Devices Sales Channels
12.4.2 Contraceptive Drugs and Devices Distributors
12.5 Contraceptive Drugs and Devices Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Global Contraceptive Drugs and Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Vaginal
    Table 4. Major Manufacturers of Injectable Contraceptive Drugs
    Table 5. Major Manufacturers of Male/Female Contraceptive Devices
    Table 6. Global Contraceptive Drugs and Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Contraceptive Drugs and Devices Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 8. Global Contraceptive Drugs and Devices Sales by Region (2017-2022) & (K Units)
    Table 9. Global Contraceptive Drugs and Devices Sales Market Share by Region (2017-2022)
    Table 10. Global Contraceptive Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2017-2022)
    Table 12. Global Contraceptive Drugs and Devices Sales Forecast by Region (2023-2028) & (K Units)
    Table 13. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Region (2023-2028)
    Table 14. Global Contraceptive Drugs and Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 15. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Region (2023-2028)
    Table 16. Top Contraceptive Drugs and Devices Regions (Countries) Ranking by Market Size (US$ Million) in 2021
    Table 17. Contraceptive Drugs and Devices Market Trends
    Table 18. Contraceptive Drugs and Devices Market Drivers
    Table 19. Contraceptive Drugs and Devices Market Challenges
    Table 20. Contraceptive Drugs and Devices Market Restraints
    Table 21. Global Contraceptive Drugs and Devices Sales by Manufacturers (2017-2022) & (K Units)
    Table 22. Global Contraceptive Drugs and Devices Sales Share by Manufacturers (2017-2022)
    Table 23. Global Contraceptive Drugs and Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Ranking of Global Top Contraceptive Drugs and Devices Manufacturers by Revenue (US$ Million) in 2021
    Table 25. Contraceptive Drugs and Devices Revenue Share by Manufacturers (2017-2022)
    Table 26. Global Contraceptive Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2021)
    Table 28. Key Manufacturers Contraceptive Drugs and Devices Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
    Table 29. Key Manufacturers Contraceptive Drugs and Devices Plants/Factories Distribution
    Table 30. Key Manufacturers Contraceptive Drugs and Devices Area Served
    Table 31. Date of Key Manufacturers Enter into Contraceptive Drugs and Devices Market
    Table 32. Key Manufacturers Contraceptive Drugs and Devices Product Type
    Table 33. Mergers & Acquisitions, Expansion Plans
    Table 34. Global Contraceptive Drugs and Devices Sales (K Units) by Type (2017-2022)
    Table 35. Global Contraceptive Drugs and Devices Sales Share by Type (2017-2022)
    Table 36. Global Contraceptive Drugs and Devices Revenue (US$ Million) Market Share by Type (2017-2022)
    Table 37. Global Contraceptive Drugs and Devices Price (K Units) by Type (2017-2022)
    Table 38. Global Contraceptive Drugs and Devices Sales (K Units) by Type (2023-2028)
    Table 39. Global Contraceptive Drugs and Devices Sales Share by Type (2023-2028)
    Table 40. Global Contraceptive Drugs and Devices Revenue (US$ Million) Market Share by Type (2023-2028)
    Table 41. Global Contraceptive Drugs and Devices Revenue Share by Type (2023-2028)
    Table 42. Global Contraceptive Drugs and Devices Price (K Units) by Type (2023-2028)
    Table 43. Global Contraceptive Drugs and Devices Sales (K Units) by Application (2017-2022)
    Table 44. Global Contraceptive Drugs and Devices Sales Share by Application (2017-2022)
    Table 45. Global Contraceptive Drugs and Devices Revenue (US$ Million) Market Share by Application (2017-2022)
    Table 46. Global Contraceptive Drugs and Devices Price (K Units) by Application (2017-2022)
    Table 47. Global Contraceptive Drugs and Devices Sales (K Units) by Application (2023-2028)
    Table 48. Global Contraceptive Drugs and Devices Sales Share by Application (2023-2028)
    Table 49. Global Contraceptive Drugs and Devices Revenue (US$ Million) Market Share by Application (2023-2028)
    Table 50. Global Contraceptive Drugs and Devices Revenue Share by Application (2023-2028)
    Table 51. Global Contraceptive Drugs and Devices Price (K Units) by Application (2023-2028)
    Table 52. North America Contraceptive Drugs and Devices Sales by Company (2017-2022) & (K Units)
    Table 53. North America Contraceptive Drugs and Devices Sales Market Share by Company (2017-2022)
    Table 54. North America Contraceptive Drugs and Devices Revenue by Company (2017-2022) & (US$ Million)
    Table 55. North America Contraceptive Drugs and Devices Revenue Market Share by Company (2017-2022)
    Table 56. North America Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
    Table 57. North America Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
    Table 58. North America Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 59. North America Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 60. North America Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
    Table 61. North America Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
    Table 62. North America Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 63. North America Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 64. North America Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
    Table 65. North America Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
    Table 66. North America Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 67. North America Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 68. Europe Contraceptive Drugs and Devices Sales by Company (2017-2022) & (K Units)
    Table 69. Europe Contraceptive Drugs and Devices Sales Market Share by Company (2017-2022)
    Table 70. Europe Contraceptive Drugs and Devices Revenue by Company (2017-2022) & (US$ Million)
    Table 71. Europe Contraceptive Drugs and Devices Revenue Market Share by Company (2017-2022)
    Table 72. Europe Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
    Table 73. Europe Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
    Table 74. Europe Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Europe Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Europe Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
    Table 77. Europe Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
    Table 78. Europe Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Europe Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Europe Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
    Table 81. Europe Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
    Table 82. Europe Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 83. Europe Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Contraceptive Drugs and Devices Sales by Company (2017-2022) & (K Units)
    Table 85. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Company (2017-2022)
    Table 86. Asia Pacific Contraceptive Drugs and Devices Revenue by Company (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Company (2017-2022)
    Table 88. Asia Pacific Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
    Table 89. Asia Pacific Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
    Table 90. Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Asia Pacific Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
    Table 93. Asia Pacific Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
    Table 94. Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2017-2022) & (K Units)
    Table 97. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2023-2028) & (K Units)
    Table 98. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 99. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 100. Latin America Contraceptive Drugs and Devices Sales by Company (2017-2022) & (K Units)
    Table 101. Latin America Contraceptive Drugs and Devices Sales Market Share by Company (2017-2022)
    Table 102. Latin America Contraceptive Drugs and Devices Revenue by Company (2017-2022) & (US$ Million)
    Table 103. Latin America Contraceptive Drugs and Devices Revenue Market Share by Company (2017-2022)
    Table 104. Latin America Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
    Table 105. Latin America Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
    Table 106. Latin America Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 107. Latin America Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 108. Latin America Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
    Table 109. Latin America Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
    Table 110. Latin America Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 111. Latin America Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 112. Latin America Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
    Table 113. Latin America Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
    Table 114. Latin America Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 115. Latin America Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 116. Middle East and Africa Contraceptive Drugs and Devices Sales by Company (2017-2022) & (K Units)
    Table 117. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Company (2017-2022)
    Table 118. Middle East and Africa Contraceptive Drugs and Devices Revenue by Company (2017-2022) & (US$ Million)
    Table 119. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Company (2017-2022)
    Table 120. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2017-2022) & (K Units)
    Table 121. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2023-2028) & (K Units)
    Table 122. Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 123. Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 124. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2017-2022) & (K Units)
    Table 125. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2023-2028) & (K Units)
    Table 126. Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 127. Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 128. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2017-2022) & (K Units)
    Table 129. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2023-2028) & (K Units)
    Table 130. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 131. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 132. Bayer Healthcare Corporation Information
    Table 133. Bayer Healthcare Description and Overview
    Table 134. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Bayer Healthcare Contraceptive Drugs and Devices Product and Services
    Table 136. Bayer Healthcare Contraceptive Drugs and Devices SWOT Analysis
    Table 137. Bayer Healthcare Recent Developments
    Table 138. Merck Corporation Information
    Table 139. Merck Description and Overview
    Table 140. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Merck Contraceptive Drugs and Devices Product and Services
    Table 142. Merck Contraceptive Drugs and Devices SWOT Analysis
    Table 143. Merck Recent Developments
    Table 144. Church & Dwight Corporation Information
    Table 145. Church & Dwight Description and Overview
    Table 146. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Church & Dwight Contraceptive Drugs and Devices Product and Services
    Table 148. Church & Dwight Contraceptive Drugs and Devices SWOT Analysis
    Table 149. Church & Dwight Recent Developments
    Table 150. Warmer Chilcott Corporation Information
    Table 151. Warmer Chilcott Description and Overview
    Table 152. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Warmer Chilcott Contraceptive Drugs and Devices Product and Services
    Table 154. Warmer Chilcott Contraceptive Drugs and Devices SWOT Analysis
    Table 155. Warmer Chilcott Recent Developments
    Table 156. Agile Therapeutics Corporation Information
    Table 157. Agile Therapeutics Description and Overview
    Table 158. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Agile Therapeutics Contraceptive Drugs and Devices Product and Services
    Table 160. Agile Therapeutics Contraceptive Drugs and Devices SWOT Analysis
    Table 161. Agile Therapeutics Recent Developments
    Table 162. Pfizer Corporation Information
    Table 163. Pfizer Description and Overview
    Table 164. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Pfizer Contraceptive Drugs and Devices Product and Services
    Table 166. Pfizer Contraceptive Drugs and Devices SWOT Analysis
    Table 167. Pfizer Recent Developments
    Table 168. BioSante Pharmaceuticals Corporation Information
    Table 169. BioSante Pharmaceuticals Description and Overview
    Table 170. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 171. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product and Services
    Table 172. BioSante Pharmaceuticals Contraceptive Drugs and Devices SWOT Analysis
    Table 173. BioSante Pharmaceuticals Recent Developments
    Table 174. Mayer Laboratories Corporation Information
    Table 175. Mayer Laboratories Description and Overview
    Table 176. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 177. Mayer Laboratories Contraceptive Drugs and Devices Product and Services
    Table 178. Mayer Laboratories Contraceptive Drugs and Devices SWOT Analysis
    Table 179. Mayer Laboratories Recent Developments
    Table 180. Pantarhei Bioscience Corporation Information
    Table 181. Pantarhei Bioscience Description and Overview
    Table 182. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 183. Pantarhei Bioscience Contraceptive Drugs and Devices Product and Services
    Table 184. Pantarhei Bioscience Contraceptive Drugs and Devices SWOT Analysis
    Table 185. Pantarhei Bioscience Recent Developments
    Table 186. Teva Pharmaceutical Industries Corporation Information
    Table 187. Teva Pharmaceutical Industries Description and Overview
    Table 188. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
    Table 189. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product and Services
    Table 190. Teva Pharmaceutical Industries Contraceptive Drugs and Devices SWOT Analysis
    Table 191. Teva Pharmaceutical Industries Recent Developments
    Table 192. Key Raw Materials Lists
    Table 193. Raw Materials Key Suppliers Lists
    Table 194. Contraceptive Drugs and Devices Distributors List
    Table 195. Contraceptive Drugs and Devices Customers List
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Contraceptive Drugs and Devices Product Picture
    Figure 2. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2021 & 2028
    Figure 3. Oral Product Picture
    Figure 4. Vaginal Product Picture
    Figure 5. Injectable Contraceptive Drugs Product Picture
    Figure 6. Male/Female Contraceptive Devices Product Picture
    Figure 7. Global Contraceptive Drugs and Devices Sales Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Use Case
    Figure 9. Pharmacies Use Case
    Figure 10. Others Use Case
    Figure 11. Contraceptive Drugs and Devices Report Years Considered
    Figure 12. Global Contraceptive Drugs and Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Contraceptive Drugs and Devices Market Size 2017-2028 (US$ Million)
    Figure 14. Global Contraceptive Drugs and Devices Sales (2017-2022) & (K Units)
    Figure 15. Global Contraceptive Drugs and Devices Market Size Market Share by Region: 2021 VS 2028
    Figure 16. Global Contraceptive Drugs and Devices Sales Market Share by Region (2017-2022)
    Figure 17. Global Contraceptive Drugs and Devices Sales Market Share by Region in 2021
    Figure 18. Global Contraceptive Drugs and Devices Revenue Market Share by Region in 2017 VS 2021
    Figure 19. Global Contraceptive Drugs and Devices Sales Share by Manufacturers in 2021
    Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Contraceptive Drugs and Devices Sales in 2021
    Figure 21. Contraceptive Drugs and Devices Revenue Share by Manufacturers in 2021
    Figure 22. Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 23. Global Contraceptive Drugs and Devices Revenue Share by Type (2017-2022)
    Figure 24. Global Contraceptive Drugs and Devices Revenue Growth Rate by Type in 2017 & 2021
    Figure 25. Global Contraceptive Drugs and Devices Revenue Share by Application (2017-2022)
    Figure 26. Global Contraceptive Drugs and Devices Revenue Growth Rate by Application in 2017 & 2021
    Figure 27. North America Contraceptive Drugs and Devices Sales Market Share by Type (2017-2028)
    Figure 28. North America Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2028)
    Figure 29. North America Contraceptive Drugs and Devices Sales Market Share by Application (2017-2028)
    Figure 30. North America Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2028)
    Figure 31. North America Contraceptive Drugs and Devices Sales Share by Country (2017-2028)
    Figure 32. North America Contraceptive Drugs and Devices Revenue Share by Country (2017-2028)
    Figure 33. U.S. Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 34. Canada Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 35. Europe Contraceptive Drugs and Devices Sales Market Share by Type (2017-2028)
    Figure 36. Europe Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2028)
    Figure 37. Europe Contraceptive Drugs and Devices Sales Market Share by Application (2017-2028)
    Figure 38. Europe Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2028)
    Figure 39. Europe Contraceptive Drugs and Devices Sales Share by Country (2017-2028)
    Figure 40. Europe Contraceptive Drugs and Devices Revenue Share by Country (2017-2028)
    Figure 41. Germany Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 42. France Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 43. U.K. Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 44. Italy Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 45. Russia Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 46. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Type (2017-2028)
    Figure 47. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2028)
    Figure 48. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Application (2017-2028)
    Figure 49. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2028)
    Figure 50. Asia Pacific Contraceptive Drugs and Devices Sales Share by Region (2017-2028)
    Figure 51. Asia Pacific Contraceptive Drugs and Devices Revenue Share by Region (2017-2028)
    Figure 52. China Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 53. Japan Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 54. South Korea Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 55. India Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 56. Australia Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 57. Taiwan Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 58. Indonesia Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 59. Thailand Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 60. Malaysia Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 61. Philippines Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 62. Vietnam Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 63. Latin America Contraceptive Drugs and Devices Sales Market Share by Type (2017-2028)
    Figure 64. Latin America Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2028)
    Figure 65. Latin America Contraceptive Drugs and Devices Sales Market Share by Application (2017-2028)
    Figure 66. Latin America Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2028)
    Figure 67. Latin America Contraceptive Drugs and Devices Sales Share by Country (2017-2028)
    Figure 68. Latin America Contraceptive Drugs and Devices Revenue Share by Country (2017-2028)
    Figure 69. Mexico Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 70. Brazil Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 71. Argentina Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 72. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Type (2017-2028)
    Figure 73. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Type (2017-2028)
    Figure 74. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Application (2017-2028)
    Figure 75. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Application (2017-2028)
    Figure 76. Middle East and Africa Contraceptive Drugs and Devices Sales Share by Country (2017-2028)
    Figure 77. Middle East and Africa Contraceptive Drugs and Devices Revenue Share by Country (2017-2028)
    Figure 78. Turkey Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 79. Saudi Arabia Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 80. U.A.E Contraceptive Drugs and Devices Revenue (2017-2028) & (US$ Million)
    Figure 81. Contraceptive Drugs and Devices Value Chain
    Figure 82. Contraceptive Drugs and Devices Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Ovarian Glandular Supplement Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-18N11423
Tue Jan 31 00:00:00 UTC 2023

Add to Cart

Global Reusable Vaginal Speculum Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-23T12696
Mon Jan 30 00:00:00 UTC 2023

Add to Cart

Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-11136
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Pheromones Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-24Z519
Thu Jan 26 00:00:00 UTC 2023

Add to Cart